Stanford Developing Targeted Sequencing Test for Mitochondrial Disease Using Long Padlock Probes
April 19, 2011
Stanford Developing Targeted Sequencing Test for Mitochondrial Disease Using Long Padlock Probes
The Stanford researchers are currently targeting 524 nuclear-encoded mitochondrial genes, including those known to be involved in mitochondrial disorders and others with related biological functions. Their ultimate goal is to develop a diagnostic test.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Clinical Genome Sequencing Requires Better Standards for Accuracy, Completeness, NHGRI Team Says
August 24, 2011 / Clinical Sequencing News - Illumina and University of Oxford to Sequence 500 Human Genomes to Inform Diagnosis, Treatment
August 3, 2011 / Clinical Sequencing News - Illumina Sees Clinical Applications for MiSeq; Plans FDA Submission in 2012
August 3, 2011 / Clinical Sequencing News - IOM Workshop Discusses Interim Strategies to Handle Unresolved Challenges of Clinical Sequencing
July 27, 2011 / Clinical Sequencing News - Sequenom Signs Supply Deal for T21 Test with Illumina; Firms to Collaborate on Regulatory Approval
July 12, 2011 / Clinical Sequencing News